Excellent
Fully Aligned
Patient Risk:
Low
Summary
The claim is explicitly supported by the provided label text: Prolia patients with advanced chronic kidney disease (eGFR <30 mL/min/1.73 m^2, including dialysis) are at greater risk for severe hypocalcemia, with reports including hospitalization, life-threatening events, and fatal cases, and the label includes corresponding monitoring and counseling guidance.
Category Scores
Accurate Statements
Severe hypocalcemia in patients with advanced kidney disease
Supported by Warnings and Precautions 5.1 and Use in Specific Populations 8.6: advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m^2, including dialysis-dependent patients) is at greater risk for severe hypocalcemia, with reports including hospitalization, life-threatening events, and fatal cases.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
No incorrect or unsafe claims were made; the statement is directly supported by label warnings regarding increased risk of severe hypocalcemia in advanced chronic kidney disease patients.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement